Molecular Partners Ag MOLN
NASDAQ MOLN
$3.61 -0.11 (-2.98%)
As of: Oct 22, 2026 · 10:34 AM EDT

Molecular Partners Ag (MOLN) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Molecular Partners Ag (MOLN) posted Return on Capital Employed [ROCE] of -71.29% for Q2 2026, down 119.97 percentage points from 48.68% a year earlier and down 7.85 percentage points from the prior quarter.

Analysis

Molecular Partners Ag (MOLN) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Molecular Partners Ag's Return on Capital Employed [ROCE] came in at -50.64%, down 87.59 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a four-year change of -2.17 percentage points (FY2021 to FY2025).
  • In prior years, Molecular Partners Ag's Return on Capital Employed [ROCE] was 36.95% in FY2024 (+66.30 pp), -29.35% in FY2023 (-86.51 pp), 57.16% in FY2022 (+105.63 pp) and -48.47% in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2021.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last three quarters, with an average year-over-year change of -1.24 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2022, with a gain of 98.50 percentage points; the weakest was Q2 2026, with a drop of 119.97 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -63.44% (Q1 2026), -57.99% (Q4 2025) and 52.83% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,171.71 Bn 1,140.30 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 642.13 Bn 560.65 Bn 17.26 Bn 17.83%
3 AbbVie 501.64 Bn 474.75 Bn 12.70 Bn 17.92%
4 Merck 375.66 Bn 330.04 Bn 12.21 Bn 6.28%
5 Novartis Ag 302.79 Bn 266.78 Bn 11.24 Bn 19.32%
6 Astrazeneca 268.68 Bn 242.37 Bn 12.86 Bn 16.76%
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn 16.66%
8 Gilead Sciences 193.69 Bn 167.89 Bn 6.22 Bn -5.97%
9 Pfizer 172.47 Bn 119.12 Bn 10.94 Bn 11.86%
10 Molecular Partners Ag 134.52 Mn -296.72 Mn - -72.86%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -72.86%
Mar 31, 2026 -63.66%
Dec 31, 2025 -57.67%
Sep 30, 2025 -53.07%
Jun 30, 2025 -51.21%
Mar 31, 2025 -43.98%
Dec 31, 2024 -41.52%
Sep 30, 2024 -41.00%
Jun 30, 2024 -37.71%
Mar 31, 2024 -33.76%
Dec 31, 2023 -30.96%
Sep 30, 2023 -27.98%
Jun 30, 2023 -26.46%
Mar 31, 2023 -20.68%
Dec 31, 2022 47.80%
Sep 30, 2022 44.87%
Jun 30, 2022 42.33%
Mar 31, 2022 50.44%
Dec 31, 2021 -50.47%
API Access

Molecular Partners Ag Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MOLN&period=max&api_key=YOUR_API_KEY